IMMUNOCORE HOLDINGS PLC

Insiders Immunocore Holdings plc

Equities

IMCR

US45258D1054

Real-time Estimate Cboe BZX Other stock markets 14:37:41 24/06/2024 BST			5-day change	1st Jan Change
35.97 ^USD	+0.11%		-6.58%	-47.41%

06-18	Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment	MT
06-18	Immunocore Holdings plc Announces Randomization of First Patient in the Global, Registrational Phase 3 Clinical Trial Testing Brenetafusp for the Treatment of First-Line Advanced or Metastatic Cutaneous Melanoma	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Immunocore Holdings plc Appoints Ranjeev Krishana to Serve as A Class I Director	05-28	CI
Immunocore Holdings Insider Sold Shares Worth $305,781, According to a Recent SEC Filing	01-05	MT
Immunocore Holdings plc Appoints Siddharth Kaul as A Non-Executive Member of Its Board of Directors	09/06/22	CI
Immunocore Announces Key Appointments to Management and Board	16/02/21	CI
Immunocore Announces the Appointment of Professor Sir Peter J. Ratcliffe as Non-Executive Director, Effective 1 November 2020	15/10/20	CI
Immunocore Appoints Brian Di Donato as Chief Financial Officer and Head of Strategy	06/05/20	CI
Immunocore Limited Names David Berman as Head of R&D	15/01/19	CI
Immunocore Limited Appoints Bahija Jallal as Chief Executive Officer and Director of the Board	04/01/19	CI
Immunocore Limited Announces Executive Changes	08/02/18	CI
Immunocore Limited Appoints Andrew Hotchkiss as Chief Commercial Officer	04/10/17	CI
Immunocore Limited Announces Executive Appointments	12/05/17	CI
Immunocore Limited Appoints Paul Fry as Chief Financial Officer	12/10/16	CI
Immunocore Limited Appoints Christina Coughlin as Chief Medical Officer	01/04/15	CI
Immunocore Limited Appoints Sir John Bell to its Board of Directors	30/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer